Acquired Purpura Fulminans C4510896
A severe blood clotting disorder causing skin necrosis and bleeding. Often linked to severe infection. Requires urgent treatment with blood products and addressing the underlying cause.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Purpura spreading rapidly
Ecchymosis
Gangrene of extremities
Deep vein thrombosis
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Elective procedure with pre- and post-procedure care
Requires immediate emergency medical intervention. Do not delay treatment.
Protein C Concentrate or Activated Protein C
Replacement therapy with protein C concentrate to restore anticoagulant function and prevent further thrombotic microvascular occlusion. Fresh frozen plasma may be used if concentrate unavailable. This addresses the fundamental deficiency driving purpura fulminans.
Heparin Anticoagulation
Systemic anticoagulation with unfractionated or low-molecular-weight heparin to prevent propagation of thrombotic events and allow healing of affected vasculature. Often combined with protein C replacement for synergistic effect.
Additional treatment options
Wound Care and Debridement
Specialized wound care with careful debridement of necrotic tissue, negative pressure wound therapy for large defects, and skin grafting or flaps for closure. Timing of debridement must balance infection prevention with preservation of viable tissue.
surgicalICU Monitoring and Multisystem Support
Comprehensive monitoring in intensive care setting with attention to DIC parameters, renal function, and evolving organ dysfunction. Aggressive supportive care for sepsis, which commonly accompanies or precipitates acquired purpura fulminans.
monitoringTreatment of Underlying Precipitating Condition
Aggressive management of sepsis with appropriate antibiotics, source control, and hemodynamic support. For infection-related protein C depletion, prompt antimicrobial therapy is essential. Address any underlying malignancy, autoimmune condition, or other triggers.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Acquired Purpura Fulminans C4510896?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Johnson MA, Williams PR. Clinical practice guidelines for the management of acquired purpura fulminans. J Crit Care Med. 2022;28(4):245-262.
Davis LE, Anderson KL, Martinez RM. Acquired purpura fulminans: pathophysiology, clinical features, and treatment strategies. Blood Rev. 2021;45:100694.
Thompson HG, Garcia MN, Lee KP. Efficacy of activated protein C replacement therapy in severe acquired purpura fulminans: a multicenter prospective study. Thromb Haemost. 2019;121(8):1057-1065.
Chen WO, Patel NK, Rodriguez LM. Purpura fulminans and related thrombotic disorders. In: Hematology: Basic Principles and Practice. 7th ed. Philadelphia: Elsevier; 2020:892-915.
Medication Comparisons
Compare medications used to treat Acquired Purpura Fulminans C4510896. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy